MTOR and neoplasm: To sum up, the above data elucidated that p-mTOR expression was positively correlated with tumor size, pathological stage and metastasis status, and inversely correlated with CSS, which indicated that p-mTOR could be a predictor of tumor aggressiveness for ccRCC patients (Rausch et al., 2019).